Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Operating Expenses: 2019-2025

Historic Operating Expenses for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $28.8 million.

  • Biodesix's Operating Expenses rose 7.77% to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.7 million, marking a year-over-year increase of 12.41%. This contributed to the annual value of $105.8 million for FY2024, which is 17.02% up from last year.
  • As of Q3 2025, Biodesix's Operating Expenses stood at $28.8 million, which was down 3.09% from $29.7 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Operating Expenses registered a high of $34.4 million during Q1 2021, and its lowest value of $18.9 million during Q4 2021.
  • Moreover, its 3-year median value for Operating Expenses was $26.2 million (2024), whereas its average is $25.6 million.
  • As far as peak fluctuations go, Biodesix's Operating Expenses spiked by 154.84% in 2021, and later slumped by 39.01% in 2022.
  • Biodesix's Operating Expenses (Quarterly) stood at $18.9 million in 2021, then climbed by 24.30% to $23.5 million in 2022, then dropped by 8.34% to $21.5 million in 2023, then climbed by 25.72% to $27.1 million in 2024, then increased by 7.77% to $28.8 million in 2025.
  • Its last three reported values are $28.8 million in Q3 2025, $29.7 million for Q2 2025, and $27.1 million during Q1 2025.